Skip to main content
. 2021 Nov 13;16:7575–7608. doi: 10.2147/IJN.S333969

Table 2.

An Overview on Nanomaterials-Based Electrochemical Methods for Exosome Detection

Methods Type of Nanomaterials Functions Cancer Types Target Biomarkers Response Time (min) Detection Limit (Particles/μL) Linear Range (Particles/μL) Ref.
Electrochemistry (direct detection) AuNPs Improving the large surface area, accelerating electrical conductivity and facilitating the immobilization of biorecognition elements Breast cancer CD63 180 4.82 × 102 5 × 102–5 × 103 [181]
BPNSs and MOFs Breast cancer CD63 Not reported 1 × 102 1.3 × 102–2.6 × 105 [182]
Electrochemistry (sandwich detection) AuNPs Nanocarriers for enzymes, electroactive molecules Liver cancer CD63 255 16.6 21.6–7.5 × 104 [189]
Zr-MOF Glioblastoma EGFR, EGFRvIII, and phosphate groups outside of exosomes 150 7.83 × 103 9.5 × 103–1.9 × 107 [190]
Zr-MOF and ZIF-8 Breast cancer CD63 and phosphate groups outside of exosomes 190 0.3 1–1 × 105 [191]
ZIF-8 Breast cancer CD63 and PD-L1 245 0.334 1–1 × 107 [192]
COFs@Au NPs Colorectal cancer CD63 and amino acid residues outside of exosomes 170 1.6 × 102 5 × 102–5 × 107 [193]
Au-NPFe2O3NC Nanozymes to catalyze the redox reaction Placental choriocarcinoma CD63 and PLAP 90 1 1–1 × 104 [194]
Ti3C2 MXene@PB Showing electroactive properties or consisting of electroactive ions Ovarian cancer CD63 120 2.29 × 102 5 × 102–5.0 × 105 [195]
CdSe QDs Colorectal adenocarcinoma CD63, HER-2 and FAM134B 130 1 × 102 1 × 102–1 × 107 [196]
Electrochemiluminescence Ru(II) markers-loaded SiNPs Nanomaterials acts as nanocarriers for molecules Hepatocellular carcinoma CD63 120 60 2 × 102–7.5 ×104 [212]
CdS:Eu QDs Electrochemiluminescence emitter Breast cancer CD63 240 74.1 3.4 × 102–1.7 × 104 [210]
CdS QDs@CaCO3 Breast cancer EpCAM 180 21 50–1 × 105 [212]
g-C3N4@Galinstan-PDA Cervical cancer GPC-1 120 31 50–1 × 105 [211]
BPQDs@ Ti3C2 MXene Coreactants Breast cancer CD63 and EpCAM 100 37 1.1 × 102–1.1 × 107 [214]
AuNPs@ Ti3C2 MXene Nanocatalysts Cervical cancer CD63 240 30 1 × 102–1 × 105 [215]
Ti3C2 MXene Breast cancer EpCAM 240 1.25 × 102 5 × 102–5 × 106 [213]
AuNPs@ g-C3N4 Ovarian cancer phosphatidylserine 120 39 1 × 102–1 × 107 [216]

Abbreviations: BPNSs, black phosphorus nanosheets; AuNPs, gold nanoparticles; MOFs, metal organic frameworks; COFs, covalent organic frameworks; Au-NPFe2O3NC, gold-loaded ferric oxide nanocubes; PB, Prussian blue; QDs, quantum dots; PDA, polydopamine; BPQDs, black phosphorus quantum dots; EGFR, epidermal growth factor receptor; EGFRvIII, epidermal growth factor receptor variant (v) III mutation; PD-L1, programmed death ligand-1; PLAP, placental alkaline phosphatase; EpCAM, epithelial cell adhesion molecule; GPC-1, glypican-1.